Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for Orthofix Medical (OFIX) over the last 16 years, with Q3 2025 value amounting to $438.4 million.

  • Orthofix Medical's Non-Current Assets fell 897.28% to $438.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 billion, marking a year-over-year decrease of 1090.33%. This contributed to the annual value of $460.0 million for FY2024, which is 888.6% down from last year.
  • As of Q3 2025, Orthofix Medical's Non-Current Assets stood at $438.4 million, which was down 897.28% from $441.3 million recorded in Q2 2025.
  • Orthofix Medical's Non-Current Assets' 5-year high stood at $512.0 million during Q3 2023, with a 5-year trough of $202.6 million in Q4 2022.
  • In the last 5 years, Orthofix Medical's Non-Current Assets had a median value of $438.4 million in 2025 and averaged $370.7 million.
  • Its Non-Current Assets has fluctuated over the past 5 years, first plummeted by 1893.71% in 2021, then skyrocketed by 15248.74% in 2023.
  • Orthofix Medical's Non-Current Assets (Quarter) stood at $207.1 million in 2021, then fell by 2.15% to $202.6 million in 2022, then surged by 149.15% to $504.9 million in 2023, then fell by 8.89% to $460.0 million in 2024, then decreased by 4.69% to $438.4 million in 2025.
  • Its last three reported values are $438.4 million in Q3 2025, $441.3 million for Q2 2025, and $432.8 million during Q1 2025.